Sign in
Download Opera News App

Stock-investment

Pfizer (NYSE:PFE) Given a $42.00 Price Target by Royal Bank of Canada Analysts

Pfizer (NYSE:PFE) Given a $42.00 Price Target by Royal Bank of Canada Analysts

Pfizer (NYSE:PFE) has been given a $42.00 price objective by Royal Bank of Canada in a research note issued to investors on Tuesday, Borsen Zeitung reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 14.07% from the stock’s previous close. PFE has been the topic of...

Read Full Story
Atlantic Securities Borsen Zeitung NYSE PFE Pfizer Royal Bank of Canada